Viewing Study NCT05800756


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-04-02 @ 5:46 AM
Study NCT ID: NCT05800756
Status: UNKNOWN
Last Update Posted: 2023-04-06
First Post: 2023-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer
Sponsor: Yantai Yuhuangding Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module